Abstract
It may sometimes be difficult to distinguish Cushing’s disease from ectopic ACTH syndrome. A case is described here of a patient with a Cushing’s syndrome and diagnostic difficulties. Initial features were consistent with a Cushing’s disease (in particular metopirone test was positive). Because of relapse of hypercortisolism after mitotane therapy, total adrenalectomy was performed. Thereafter features occurred that evoked Nelson’s syndrome, including high plasma ACTH levels and a pituitary mass syndrome. Pituitary reserve testings by vasopressin or cortico-tropin-releasing factor were positive, although inconstantly, in that plasma ACTH increased. A lung tumor was discovered about 20 yr after the first clinical signs of hypercortisolism. Its removal led to the discovery of a bronchial carcinoid tumor and was followed by normalization of plasma ACTH levels. An analysis of proopiomelanocortin-related peptides was performed postoperatively on the blood drawn before and after the tumor resection and on the tumor; the results of this study would have been contributive to the diagnosis of occult ectopic ACTH tumor. In conclusion this case demonstrates the limitations of the conventional procedures in the diagnosis of the ectopic ACTH syndrome. At contrast the newer biochemical procedures may be very useful in determining the type of hypercortisolism.
This is a preview of subscription content, log in via an institution to check access.
References
Aron D.C., Blake Tyrell J., Fitzgerald P.A., Findling J.W., Forsham P.H. Cushing’s syndrome: problems in diagnosis. Medicine 60:25, 1981.
Westphal S.A., Mariash C.N., Wick M., Oppenheimer J.H. Hypercortisolism due to an autonomously functioning pituitary adenoma: limitations in diagnostic test procedures. J. Clin. Endocrinol. Metab. 67:1105, 1988.
Proeschel M.F., Couvalain J.C., Donadieu M., Binoux M., Girard F. Preparation and evaluation of ACTH antibodies. Ann. Endocrinol. (Paris) 75: 461, 1974.
Bertagna X.Y., Luton J.P., Binoux M., Bricaire H., Girard F. Characterization of lipotropic, corticotropin-, and ß-endorphin immuno-reactive materials secreted in vitro by human pituitary adenoma responsible for a case of Nelson’s syndrome. J. Clin. Endocrinol. Metab. 49: 527, 1979.
Linton E., Mc Lean C., Nieunenhuyzen-Kruseman A., Tilders F., Van Der Veen E., Lowry P. Direct measurement of human plasma corticotropinreleasing by a “two-site” immunoradiometric assay. J. Clin. Endocrinol. Metab. 64: 1047, 1987.
Mains R.E., Eipper B.A. Phosphorylation of rat and human adrenocortico-tropin related peptides. Physiological regulation and studies of secretion. Endocrinology 112: 1995, 1983.
Vieau D., Massias J.F., Girard F., Luton J.P., Bertagna X. Corticotropin-like intermediary lobe peptide as a marker of alternate processing in ACTH-producing non-pituitary tumors. Clin. Endocrinol. 31: 691, 1989.
Singer W., Kovac K., Ryan N., Horvath E. Ectopic ACTH syndrome: clinico-pathological correlations. J. Clin. Pathol. 37: 591, 1978.
Finding J.W., Tyrrel J.B. Occult ectopic secretion of corticotropin. Arch. Intern. Med. 7/6:172, 1986.
Chrousos G.P., Schulte H.M., Oldfield E.H., Gold P.W., Cutler G.B. Jr., Loriaux L. The corticotropin-releasing factor stimulation.test. An aid in the evaluation of patients with Cushing’s syndrome. N. Engl. J. Med. 310: 622, 1984.
Malchoff C.D., Orth D.N., Abboud C., Aidan Carrey J., Pairolero P.C., Carey R.M. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, mety-rapone and corticotropin-releasing factor. Am. J. Med. 84:760, 1988.
Roth K.A., Newell D., Dorin R.F., Eberwine J.H., Hoffman A.R. Aberrant production and regulation of proopiomela-nocortin-derived peptides in ectopic Cushing’s syndrome. Horm. Metab. Res. 20: 225, 1988.
De Keyzer Y., Bertagna Y., Lenne F., Girard F., Luton J.P., Kahn A. Altered proopiomelanocortin gene expression in ad-renocorticotropin-producing nonpituitary tumors. J. Clin. Invest. 76: 1892, 1985.
Suda T., Tozawa F., Yamaguchi H., Shibasaki T., Demura H., Shizume K. Multiple forms of immunoreactive B-endorphins are present in an ectopic adrenocorticotropin-producing tumor but not in normal pituitary or pituitary adenomas. J. Clin. Endocrinol. Metab. 54:167, 1982.
Yamaji T., Ishibashi M., Teramoto A., Fukushima T. Hyperprolactinemia in Cushing’s disease and Nel son’s syndrome. J. Clin. Endocrinol. Metab. 58: 790, 1984.
Carey R.M., Vrma S.K., Drake C.R., Thorner M.O., Kovacs K., Rivier J., Vale W. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing’s syndrome. N. Engl. J. Med. 311: 13, 1984.
Belsky J.L., Cuello B., Swanson L.W., Simmons D.M., Jarrett R.M., Braza F. Cushing’s syndrome due to ectopic production of corticotropin-releasing factor. J. Clin. Endocrinol. Metab. 60: 496, 1985.
Schteingart D.E., Lloyod R.V., Akil H., Chandler W.F., Ibarra-Perez G., Rosen S.G., Ogletree R. Cushing’s syndrome secondary to ectopic cortico- tropin-releasing hormone-adrenocorticotropin secretion. J. Clin. Endocrinol. Metab. 63: 770, 1986.
Raux Deay M.C., Proeschel M.F., De Keyser Y., Bertagna W., Luton J.P., Girard F. Characterization of human corticotrophin-releasing hormone and proopiomelanocortin-related peptides in a thymic carcinoid tumor responsible for Cushing’s syndrome. Clin. Endocrinol. (Oxf.) 29: 649, 1988.
Tourniaire J., Rebattu B., Conte-Devoly B., Trouillas J., Grino M., Berger-Dutrieux N., Peix J.L., Pugeat M. Syndrome de Cushing secondaire à la production ectopique de CRF par un carcinome medullaire du corps thyroïde. Ann. Endocrinol. (Paris) 49: 61, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lalau, JD., Vieau, D., Tenenbaum, F. et al. A case of pseudo-Nelson’s syndrome: cure of ACTH hypersecretion by removal of a bronchial carcinoid tumor responsible for Cushing’s syndrome. J Endocrinol Invest 13, 531–537 (1990). https://doi.org/10.1007/BF03348619
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348619